The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Verditek falls on cash shell plans

Wed, 07th Feb 2024 09:29

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Redx Pharma PLC, up 35% at 27.00 pence, 12-month range 19.00p-60.00p. The clinical-stage biotechnology company signs an agreement to sell Kirsten rat sarcoma virus inhibitor program to Jazz Pharmaceuticals PLC. Redx says it will receive USD10 million upfront, with a potential for up to USD870 million in development, regulatory and sales milestone payments in addition to royalties on future net sales. Jazz and Redx will collaborate to advance candidates through IND-enabling studies; Jazz will be responsible for all clinical development, regulatory, manufacturing and commercialization activities.

----------

AIM - LOSERS

----------

Verditek PLC, down 19% at 0.12p, 12-month range 0.080p-1.90p. The producer of lightweight solar panels agrees terms to sell its solar business to a new company, which will be established by the holders of Verditek's secured convertible loan notes for GBP528,340 in notes and GBP50,000 in cash. Upon disposal, Verditek will be regarded as an AIM rule 15 cash shell. Verditek will therefore need to, within six months, make an acquisition or acquisitions which constitute a reverse takeover. It said that it is currently in discussions with "a group of individuals", who it is proposed would come in as a new management team with a view to completing a fundraise of about GBP300,000. The aim would be to conduct a reverse takeover within 6 months of completion of the disposal. "There is no guarantee that this proposal will proceed as it still at an exploratory stage and the company will update the market with more information as soon as it is available," Veritek adds.

----------

Helium One Global Ltd, down 16% at 1.81p, 12-month range 0.19p-10.30p. The primary helium explorer raises GBP4.7 million through a placing of 313.3 million new shares priced at 1.5p each. The placing price represents a 30% discount to the closing price of 2.16p on Tuesday. The proceeds will provide the company with "sufficient" working capital to progress its planning for the next stage of the work programme in Tanzania. Chief Executive Lorna Blaisse says: "The results that we have achieved from the Itumbula West-1 well, flowing helium to surface in such significant concentrations, has confirmed a globally unique helium producing province. By moving quickly and finalising this company led placing early on, we have been able to strengthen our working capital position, which will enable us to fully focus on the next phase of the company's growth."

----------

By Sophie Rose, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2024 Alliance News Ltd. All Rights Reserved.

More News
1 Jun 2021 15:51

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

EXECUTIVE CHANGES: Tekmar hires former Kromek CFO; Redx chair departs

Read more
1 Jun 2021 15:51

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 May 2021 16:24

EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits

EXECUTIVE CHANGES: Imperial Brands CFO enters; DF Capital chair exits

Read more
5 May 2021 16:37

IN BRIEF: Redx Pharma hires New York-based chief financial officer

IN BRIEF: Redx Pharma hires New York-based chief financial officer

Read more
28 Apr 2021 19:19

IN BRIEF: Redx Pharma starts dosing of first patient cohort of RXC004

IN BRIEF: Redx Pharma starts dosing of first patient cohort of RXC004

Read more
2 Mar 2021 21:39

TRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US

TRADING UPDATES: Chariot expects gas in Morocco; Redx wants CFO in US

Read more
23 Feb 2021 16:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
27 Jan 2021 14:06

IN BRIEF: Redx Pharma Full-Year Revenue Increases But Loss Widens

IN BRIEF: Redx Pharma Full-Year Revenue Increases But Loss Widens

Read more
20 Jan 2021 16:16

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
23 Dec 2020 15:52

Director dealings: Redx CEO ups stake

(Sharecast News) - Redx Pharma revealed on Wednesday that chief executive Lisa Anson had acquired 39,998 ordinary shares in the AIM-listed drug discovery and development group.

Read more
23 Dec 2020 14:50

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

UK DIRECTOR DEALINGS SUMMARY: San Leon Energy CEO Cancels Share Buy

Read more
21 Dec 2020 18:10

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

UK TRADING UPDATE SUMMARY: Novacyt Tests Can Spot New Virus Strain

Read more
2 Dec 2020 17:39

IN BRIEF: Redx Pharma Conditionally Raises GBP25.5 Million Via Placing

IN BRIEF: Redx Pharma Conditionally Raises GBP25.5 Million Via Placing

Read more
27 Oct 2020 15:16

IN BRIEF: Redx Pharma Hires New Chief Medical Officer From Achilles

IN BRIEF: Redx Pharma Hires New Chief Medical Officer From Achilles

Read more
9 Sep 2020 13:33

IN BRIEF: Redx Pharma Teams With Jazz To Develop Cancer Therapies

IN BRIEF: Redx Pharma Teams With Jazz To Develop Cancer Therapies

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.